These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 205366)

  • 1. Immunization of mice against murine mammary tumor virus infection and mammary tumor development.
    Sarkar NH; Moore DH
    Cancer Res; 1978 May; 38(5):1468-72. PubMed ID: 205366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
    Girardi AJ; Dion AS; Pomenti AA; Holben JA
    J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppressed murine mammary tumor virus (MuMTV) expression in RIII female mice treated neonatally with goat antiserum to MuMTV.
    Frensdorff A; Wald A
    J Natl Cancer Inst; 1978 Aug; 61(2):437-9. PubMed ID: 210290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
    Lopez DM; Lopez PF; Parks WP; Paul RD
    J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of murine mammary tumor virus antibody and antigens in normal and tumor-bearing feral mice.
    Fine DL; Arthur LO; Gardner MB
    J Natl Cancer Inst; 1978 Aug; 61(2):485-91. PubMed ID: 210292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autogenous antibodies against the murine mammary tumor virus in strains of mice with low incidences of mammary tumors.
    Michalides R; Wagenaar E; Nusse R
    J Natl Cancer Inst; 1979 Apr; 62(4):935-41. PubMed ID: 219283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of novel murine mammary tumor viruses by interspecies immunoassays.
    Teramoto YA; Hand PH; Callahan R; Schlom J
    J Natl Cancer Inst; 1980 Apr; 64(4):967-75. PubMed ID: 6154165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cellular hypersensitivity of gp55 of RIII-murine mammary tumor virus and gp55-like protein of human breast cancers.
    Black MM; Zachrau RE; Dion AS; Shore B; Fine DL; Leis HP; Williams CJ
    Cancer Res; 1976 Nov; 36(11 Pt 1):4137-42. PubMed ID: 184925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic studies with mouse mammary tumor viruses: comparative studies with spontaneous mammary tumor cell vaccines from five inbred mouse strains.
    Girardi AJ; Dion AS; Holben JA
    J Natl Cancer Inst; 1985 Jan; 74(1):105-12. PubMed ID: 2982052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse mammary tumor virus infections: viral expression and tumor risk.
    Altrock BW; Cardiff RD
    J Natl Cancer Inst; 1979 Oct; 63(4):1075-80. PubMed ID: 225501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
    McGrath CM; Prass WA; Maloney TM; Jones RF
    J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An antigen cross-reactive with gp52 of mammary tumor virus is expressed on a B cell subpopulation of mice.
    Tax A; Ewert D; Manson LA
    J Immunol; 1983 May; 130(5):2368-71. PubMed ID: 6300244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigenic determinants in a virus-induced mouse mammary tumor recognized by cell-mediated immune assays.
    Lopez PF; Parks WP; Lopez DM
    J Natl Cancer Inst; 1984 Mar; 72(3):725-32. PubMed ID: 6199544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Murine mammary tumor virus seroepidemiology in BALB/cfC3H mice: correlation with tumor development.
    Altrock BW; Cardiff RD; Blair PB
    J Natl Cancer Inst; 1981 Jul; 67(1):163-8. PubMed ID: 6265680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of acquired provirus sequences in mammary tumors from low-expressor, low-risk mice.
    Altrock BW; Cardiff RD; Puma JP; Lund JK
    J Natl Cancer Inst; 1982 Jun; 68(6):1037-41. PubMed ID: 6283224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immunity to mammary tumor virus in normal and tumor-bearing C3H/HeN mice.
    Tagliabue A; Herberman RB; McCoy JL
    Cancer Res; 1978 Aug; 38(8):2279-84. PubMed ID: 208765
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression and disposition of the murine mammary tumor virus (MuMTV) envelope gene products by murine mammary tumor cells.
    Sarkar NH; Racevskis J
    Virology; 1983 Apr; 126(1):279-300. PubMed ID: 6302986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluation of the effect of mouse mammary tumor virus infection on the BALB/c mouse hyperplastic outgrowth.
    Ashley RL; Cardiff RD; Fanning TG
    J Natl Cancer Inst; 1980 Nov; 65(5):977-86. PubMed ID: 6253710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MuMTV antigens in rabbits and rats infected with MuMTV.
    Westenbrink F; Koornstra W
    Virology; 1979 Oct; 98(2):493-6. PubMed ID: 228486
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.